Clinical Lymphoma Myeloma & Leukemia

杂志介绍

Clinical Lymphoma Myeloma & Leukemia杂志介绍

《Clinical Lymphoma Myeloma & Leukemia》是一本以English为主的未开放获取国际优秀期刊，中文名称临床淋巴瘤骨髓瘤和白血病，本刊主要出版、报道医学-HEMATOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.7，最新CiteScore 指数为2.7。

本刊近期中国学者发表的论文主要有：

• Correlation of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with susceptibility and prognosis for multiple myemola

  Author: Hongbo Wu, Ting Huang, Zhifeng Ye, Xiaoqing Fu, Keke Hu, Xuefei Yang

• Study on the prognostic value of aberrant antigen in patients with acute B lymphocytic leukemia

  Author: Jun Liu, Xu Tan, Ying-Ying Ma, Yao Liu, Li Gao, Lei Gao, PeiYang Kong, Xian-Gui Peng, Xi Zhang, Cheng Zhang

• Role of p15(INK4B) methylation in patients with myelodysplastic syndromes: a systematic meta-analysis

  Author: Fang Ye, Ningning Li

• Prognostic Value of 1q21 Gain in Multiple Myeloma

  Author: Dangui Chen, Di Zhou, Jingyan Xu, Rongfu Zhou, Jian Ouyang, Bing Chen

英文介绍

Clinical Lymphoma Myeloma & Leukemia杂志英文介绍

Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.